Status | Study |
Terminated |
Study Name: Treatment of Pemphigus Patients With Rituximab 1000mgX2 and Assessment of Immune Status Via Cylex Condition: Pemphigus Date: 2011-04-17 Interventions: Drug: Rituximab intravenous (IV) Rituximab 1 gramX2, every (q) 2 weeks. |
Terminated |
Study Name: Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus Condition: Pemphigus Date: 2011-03-10 Interventions: Drug: Sirolimus (formerly known as Rapamycin) For low to moderate immunologic risk, the loading dose is |
Completed |
Study Name: Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab Condition: Pemphigus Date: 2011-02-17 Interventions: Drug: Rituximab 375mg/m2 Other Name: Mabthéra |
Active, not recruiting |
Study Name: Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus Condition: Pemphigus Disease Date: 2008-11-03 Interventions: Drug: General Corticotherapy f |
Completed |
Study Name: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) Condition: Pemphigus Vulgaris (PV) Date: 2008-05-19 Interventions: Drug: Mycophenolate Mofetil 2 g/Day |
Completed |
Study Name: Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus Condition: Pemphigus Date: 2008-04-07 Interventions: Drug: Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine |
Completed |
Study Name: Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone Condition: Pemphigus Vulgaris Date: 2008-02-21 Interventions: Drug: Azathioprine It is given |
Completed |
Study Name: Use of KC706 for the Treatment of Pemphigus Vulgaris Condition: Pemphigus Vulgaris Date: 2008-01-22 Interventions: Drug: KC706 300 mg once daily (QD) for 12 weeks. |
Terminated |
Study Name: Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus Condition: Pemphigus Vulgaris Date: 2007-06-05 Interventions: Drug: intravenous immunoglobulin |
Terminated |
Study Name: Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris Condition: Pemphigus Vulgaris Date: 2007-01-29 Interventions: Drug: Dapsone |